Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Male pattern baldness may be linked to prostate cancer risk.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

The document corrects an author's affiliation in previous articles about COVID-19 and its links to hair loss and hormones.

Men with male pattern baldness may not have different hormone levels, but their hair follicles are likely more sensitive to hormones.

Hormones and neuropeptides affect hair growth, with androgens having opposite effects on beard and scalp hair.

Dutasteride is effective for treating hair loss.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

The development of breeding tubercles in male zebrafish relies on a specific enzyme that processes hormones.

5 alpha-reductase inhibitors, like finasteride, are used to treat conditions like prostate issues and skin disorders.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Male pattern hair loss affects up to 80% of men due to genetics and hormone sensitivity.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

5α-reductase inhibitors are effective for treating hair loss in androgenetic alopecia.

Nanocarriers could improve minoxidil delivery for better hair loss treatment.

Nanocarrier systems could improve hair loss treatments by delivering drugs more effectively.

Platelet-rich plasma injections are a promising new treatment for hair loss, showing initial positive results.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

Phytotherapy offers a safer alternative for managing hair loss with fewer side effects.

Finasteride and dutasteride may help prevent hair loss but could cause side effects like sexual dysfunction and psychological issues.

De nouvelles thérapies promettent de mieux traiter la perte de cheveux due à l'alopécie androgénétique.

Phellodendri Cortex Extract may help treat enlarged prostate.